Transarterial Radioembolization Slows Development of CRC With Liver Mets
Transarterial yttrium-90 radioembolization (TARE) blended with 2nd-line chemotherapy improved progression-free survival (PFS) in sufferers with unresectable colorectal cancer liver metastases, in response to results from the randomized section III EPOCH trial. With the addition of TARE, median PFS elevated from…